Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Warfarin in AF with Mitral Stenosis
NCT05540587Phase 2Recruiting
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edoxaban in Atrial fibrillation (AFib), mitral valve stenosis. Started May 2022; status: recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)mitral valve stenosis
Beyond the preview
Go deeper on NCT05540587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540587.